Zai Lab Limited American Depositary Shares
$24.67
-$0.13 (-0.52%)
$24.42Day Range$25.32
Key Statistics
Market Cap
$2.78B
Shares Outstanding
112.3M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Sep 20, 2017
Round Lot
100
Locale
US
Trading Data
Day Open
$24.90
Day High
$25.32
Day Low
$24.42
Volume
1.16M
VWAP
$24.89
Prev Close
$24.80
Transactions
--
Acc. Volume
--
About Zai Lab Limited American Depositary Shares
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
PHARMACEUTICAL PREPARATIONSSIC 28341,797 employees899 HALEI ROAD, SHANGHAI862161632588IPO Sep 20, 2017US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001704292
- Composite FIGI
- BBG00HFX3N90
- Share Class FIGI
- BBG00HFX3P04
- Ticker Root
- ZLAB
- SIC Code
- 2834
About Zai Lab Limited American Depositary Shares (ZLAB) Stock
Zai Lab Limited American Depositary Shares (ZLAB) closed the 2026-09-16 session at $24.67, down 0.52% versus the previous close (-0.13). The stock opened at $24.90 and traded between $24.42 and $25.32 during that session. Session trading volume was 1.2M shares. The volume-weighted average price (VWAP) is $24.89.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Zai Lab Limited American Depositary Shares has a market capitalization of $2.78 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ZLAB is listed on the XNAS exchange. The company employs approximately 1,797 people. The recorded listing date is 2017-09-20.
On this page you can find market ZLAB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.